Redox announced today it is partnering with OpiSafe, a company with a platform designed to manage the opioid response for providers, patients and first responders.

According to a release, the partnership will expand the use of OpiSafe’s comprehensive pain medication management web and mobile platforms to help thousands of providers across the country prescribe and treat pain more effectively while avoiding bad outcomes.

“OpiSafe is placing premium value on developing and deploying innovative digital applications to meet the challenges of state and local opioid responses and the need for comprehensive frameworks for tackling substance abuse and behavioral health,” Redox President Niko Skievaski said in a statement. “With the Redox hub in place, it will be easy for OpiSafe to build a network that unleashes a huge amount of data for providers and patients.”

Financial details about the partnership were not disclosed.